- Open Access
Functional analysis of bovine TLR5 and association with IgA responses of cattle following systemic immunisation with H7 flagella
© Tahoun et al.; licensee BioMed Central. 2015
- Received: 12 July 2014
- Accepted: 11 December 2014
- Published: 19 February 2015
Flagellin subunits are important inducers of host immune responses through activation of TLR5 when extracellular and the inflammasome if cytosolic. Our previous work demonstrated that systemic immunization of cattle with flagella generates systemic and mucosal IgA responses. The IgA response in mice is TLR5-dependent and TLR5 can impact on the general magnitude of the adaptive response. However, due to sequence differences between bovine and human/murine TLR5 sequences, it is not clear whether bovine TLR5 (bTLR5) is able to stimulate an inflammatory response following interaction with flagellin. To address this we have examined the innate responses of both human and bovine cells containing bTLR5 to H7 flagellin from E. coli O157:H7. Both HEK293 (human origin) and embryonic bovine lung (EBL) cells transfected with bTLR5 responded to addition of H7 flagellin compared to non-transfected controls. Responses were significantly reduced when mutations were introduced into the TLR5-binding regions of H7 flagellin, including an R90T substitution. In bovine primary macrophages, flagellin-stimulated CXCL8 mRNA and secreted protein levels were significantly reduced when TLR5 transcript levels were suppressed by specific siRNAs and stimulation was reduced with the R90T-H7 variant. While these results indicate that the bTLR5 sequence produces a functional flagellin-recognition receptor, cattle immunized with R90T-H7 flagella also demonstrated systemic IgA responses to the flagellin in comparison to adjuvant only controls. This presumably either reflects our findings that R90T-H7 still activates bTLR5, albeit with reduced efficiency compared to WT H7 flagellin, or that other flagellin recognition pathways may play a role in this mucosal response.
- CXCL8 mRNA
- CXCL8 Secretion
- Bovine Macrophage
- TLR5 Sequence
- Flagellin Monomer
Flagella have been shown to play a significant role in bacterial pathogenesis, primarily through their function as motility organelles, but also as adhesins and as pro-inflammatory agonists. As a consequence, flagella have been trialled as vaccine antigens in a number of species [1-5] and it is evident that flagellins promote specific immune responses and may increase the magnitude of the response, functioning as an adjuvant for the presentation of heterologous antigens [6,7]. It has been demonstrated in cattle that systemic vaccination with H7 flagella leads to the production of IgA and IgG1 against FliCH7 with both IgA and IgG1 detected at the mucosal surface [3,8,9]. Toll like receptors (TLRs) are crucial components that allow recognition of microbial associated molecular patterns (MAMPs), including Lipid A of LPS, lipoteichoic acid, peptidoglycan, certain nucleic acids and flagellin [10,11]. TLRs are a family of transmembrane proteins, each consisting of a Leucine-rich extracellular domain (ectodomain) that recognizes distinct MAMPs and hence is variable between different TLRs. Most TLRs form dimers following MAMP binding and some TLRs can function as heterodimers, for example TLR2 makes a heterodimer with TLR6 to sense lipoteichoic acid and a heterodimer with TLR1 to sense lipid-protein combination .
TLR5 recognises the flagellin monomer [13,14] and they are considered to form a TLR5:flagellin complex with a 2:2 stoichiometry . TLRs have an intracellular domain (endodomain) that is relatively conserved between the different TLRs including the presence of a toll/interleukin-1 (TIR) region that contains specific amino acids that are phosphorylated upon MAMP binding and can then interact with different adaptor proteins leading to signalling cascades resulting in pro-inflammatory cytokine release [16,11]. In terms of flagellin, it is evident that specific residues within the more conserved D1 domains are required for binding to the TLR5 ectodomain, with the more variable D2 and D3 regions responsible for the antigenic variability of flagellins . While the D0 and D1 domains of flagellin are relatively conserved, variation in these regions has been shown to limit innate responses to flagellin expressed by α and ε Proteobacteria, including Helicobacter pylori [18,19].
Recent research in mice has indicated that induction of IgA following systemic immunization with flagellin from Salmonella enterica serovar Typhimurium is considered to be dependent on the capacity of monomeric flagellin to stimulate toll-like receptor 5 (TLR5) signalling in specific intestinal dendritic cells . Another study in mice has also shown that the magnitude of the response to flagellin as an antigen is also TLR5-dependent . There is 79% amino acid homology between the bovine (NP_001035591.1) and human (NP_003259.2) TLR5 sequences. In cattle (Bos taurus), there are specific changes in both the extracellular domain and the TIR domain in TLR5 in comparison to other mammalian sequences . For example, codon S268 has been positively selected in the artiodactyl clade  and is within the LRR9 loop region identified by Yoon et al.  as being particularly important in the TLR5 interaction with the N- and C-terminal helices of the flagellin D1 domain. Variation in the human and murine amino acids at this site (TLR5 268) has also been shown to at least partially account for differences between these species in their interactions with flagellins . With the addition of further artiodactyla TLR5 sequences we have identified a further potentially functional change in bovine TLR5 at position 798 in the TIR region, which in most species including humans and mice is a tyrosine, but in cattle and other ruminants is a Phenylalanine. It has been suggested that Tyr798 plays an important role in TLR5 signaling as mutation of murine TLR5 Tyr798 to Leu798 resulted in negligible capacity to signal in response to flagellin . Very recent work demonstrated that bovine TLR5 transfected into HEK293T cells did not appear to signal. However there was some indication of P38 phosphorylation in bovine macrophages following addition of flagella although there was no indication as to whether this was TLR5-dependent . Taken together, it is unclear whether TLR5 is functionally important in the recognition of flagellin in cattle.
Nonetheless, systemic immunization in cattle with H7 flagellin induces IgA responses [3,8] in line with similar murine responses to flagellin that were dependent on TLR5 [20,21,23]. This might indicate that these bovine IgA responses are also TLR5-dependent and that bovine TLR5 is functional despite variation in the ectodomain and the TIR domain. To test this we have transfected bovine TLR5 (bTLR5) clones into both human HEK293 and bovine EBL cells and analysed responses following stimulation with wild type H7 and with flagellins engineered to contain site-specific mutations in the TLR5-binding domains. We also investigated gene expression and CXCL8 secretion from bovine peripheral blood monocyte-derived macrophages following addition of H7 flagellin, with and without siRNA knock-down of bovine TLR5 expression. Finally, immunization studies were carried out in cattle comparing stimulation of mucosal humoral responses following systemic delivery of H7 flagella and a variant with reduced capacity to stimulate TLR5.
Flagella expression and purification
Bacterial strains used in the study
TUV93-0 ΔfliC transformed with pEW7 (fliC H7 )
TUV93-0 ΔfliC fliC transformed with pAT12
TUV93-0 ΔfliC fliC transformed with pAT13
TUV93-0 ΔfliC fliC transformed with pAT14
TUV93-0 ΔfliC fliC transformed with pAT15
TUV93-0 ΔfliC fliC transformed with pAT16
For acid preparation 1 M HCl was added on a stirring platform until a pH ~ 2 was reached and stirred for 30 min. The preparations were centrifuged at 5000 × g for 30 min. The supernatants were transferred and neutralised with 1 M NaOH. The volume of supernatants was measured and (NH4)2SO4 added to 2.67 M (35.2 g/100 mL) and left overnight at 4 °C. Then the preparations were centrifuged at 15 000 × g at 4 °C for 15 min. The supernatants were discarded and pellets suspended in PBS (2 mL for an original litre of culture). Flagella preparations were dialysed overnight three times at 4 °C in at 500-1000 volumes of PBS and stored at −20 °C.
For sheared flagella preparations, the cultures suspended in a 2% volume of PBS bacterial cultures were made up to 20 mL in PBS. The cultures were sheared for 2 min on ice with an IKA T-10 homogeniser (Ultra-Turrax). The cultures were then centrifuged at 4100 × g for 15 min. The supernatants were collected and re-centrifuged. This step was repeated 4 to 5 times until the supernatants were clear. The cleared supernatants were centrifuged at 15 000 × g for 10 min to remove any remaining bacteria. The supernatant from this step were transferred into fresh tubes and centrifuged at 145 000 × g at 4 °C for 90 min to pellet the flagella. Flagella pellets were suspended in 500 μL PBS and stored at −20 °C.
Flagellin concentrations were determined by BCA and purity by coomassie staining following separation on SDS-polyacrylamide gels.
LPS removal and monomerization of flagella
The first step to remove LPS involved repeated extraction in 1% TritonX114. This was added to flagella (1 in 500) in an Eppendorf and rotated overnight at 4 °C. The mixture was then incubated at 37 °C for 10 min and centrifuged for 15 min at 13 000 rpm in desktop centrifuge at RT. The aqueous phase was collected from clearly visible Tx114 at bottom of tube. This extraction was repeated 4 times and the collected flagellin filter-sterilized and dialyzed to remove any remaining of detergent. The second step was a column clean up using Pierce® High-Capacity Endotoxin binding resin following manufacturer’s instructions (Thermo Scientific). Endotoxin levels were measured using an EndoLISA kit according to manufacturer’s instructions (Hyglos GmbH) and expressed as endotoxin units (EU) per μg protein.
When required, monomerisation of flagellins was carried out by heating flagella at 70 °C for 15 min followed by filtration by centrifugation at 5000 × g at 4 °C for 30 min using 100 kDa 4 mL filter units (Millipore) .
Site-directed mutagenesis of H7 flagella
Primers used for H7-FliC mutagenesis
Oligonucleotide sequence (5’ – 3’)
TUV93-0 ΔfliC transformed with pEW7 (fliC H7 ) and altered alleles: pAT12 (Q89A), pAT13 (Q89D), pAT14 (R90A), pAT15 (R90T) and pAT16 (L500A/I504A) (Table 1) were stab inoculated into the centre of motility agar plates  (0.3% agar, with ampicillin and 1 mM final concentration of IPTG). The plates were incubated at 30 °C overnight and then examined for the extent of spread.
Embryonic bovine lung (EBL) cells were from laboratory stocks. The cells were grown at 37 °C in a 5% CO2 and 80% humidity in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% (v/v) (FBS, Sigma), 1 U of penicillin (Invitrogen), 1 μg/mL of streptomycin (Invitrogen) and 2 mM L-glutamine (Invitrogen). HEK293 and HEK blue (PDRIVE5s-mIFN-ß) cells were grown in the above medium with additions when required zeocin 100 μg/mL (InvivoGen), pUNo1 selection blasticidin 30 μg/mL (InvivoGen) and Normocin (100 μg/mL) (InvivoGen) was used as antifungal and mycoplasma agent.
TLR5 clones and transfections
The human and bovine TLR5 clones were obtained from InvivoGen. The human clone was supplied in embryonic kidney cells (HEK293) transfected with pUNo1-hTLR05 (InvivoGen) under control of a hEF1-HTLV promoter. These cells were also transfected with PDRIVE5s-mIFN-ß containing SEAP as a reporter for NF-κB transcriptional activation as the mIFNß promoter has four binding sites for NF-κB. Cells containing the two plasmids are referred to as “hHEK blue cells” while those just the SEAP construct are referred to as “Null cells”. Confluent cultured (HEK blue cells) were used to study the capacity of H7 flagellin to activate hTLR5. The bovine clone was supplied by InvivoGen in E. coli, and so was purified and transfected into the HEK Null cells. Permanent transfection was selected by addition of zeocin for the SEAP reporter plasmid and Blasticidin for the bTLR5 clone.
For transfection of the bovine EBLs, the bTLR5 clone was sub-cloned into a modified ptGFP1 vector . Briefly, the full-length bTLR5 was amplified using specific primers encoding bovine TLR5 alongside restriction enzymes sites XhoI and SacII (bTLR5xsFW: CTCGAGCAC CATGGGAGACTGCCTTG, bTLR5xsRV: CCGCGGCTAGGAGATGGTGG). Invivogen bTLR5 plasmid was used as a template in a 25 μL reaction containing 1 μL of plasmid, 5 μL of GoTaq colourless reaction buffer, 0.5 μL of each of the primers at 10 mM, 0.5 μL dNTP (10 mM each), 0.25 μL of a mix of 10:1 GoTaq DNA polymerase (5 U/μL) and Pfu DNA polymerase (5 U/mL) (both Promega, Madison, USA). The PCR product was then gel extracted using QIAquick Gel Extraction Kit (Qiagen Inc., Netherlands) and ligated into pGEM®-T Easy Cloning Vector (Promega, Madison, USA).
Following transformation into competent XL1-Blue Competent Cells (Stratagene, Agilent Technologies Division, USA), cells were grown on LB agar (Sigma Aldrich, USA) supplemented with X-Gal and 10 mM IPTG. White colonies were grown overnight in 5 mL of LB medium with ampicillin (100 μg/mL), in a shaking incubator at 37 °C. Plasmid DNA from 4 independent colonies was then purified using a QIAprep Plasmid DNA Miniprep kit (Qiagen Inc., Netherlands) following the manufacturer’s instructions and sent for sequencing to confirm correct sequence. The confirmed bTLR5 plasmid and modified vector ptGFP1 were then digested with XhoI and SacII at 37 °C for 3 h in a 50 μL reaction. Digestion was then purified with a QIAquick PCR Purification kit (Qiagen Inc., Netherlands) and ligated at 4 °C overnight using T4 DNA ligase (Promega, Madison, USA). Ligated products were then transformed into competent JM109 cells (Promega, Madison, USA), and seeded into LB agar + kanamycin (50 μg/mL). Positive colonies were grown overnight in 5 mL of LB medium with kanamycin in a shaking incubator at 37 °C. Plasmid DNA was purified as above and concentrations determined by spectrophotometry (Nanodrop, Labtech International, UK).
EBL cells were incubated in DMEM media supplemented with 10% foetal calf serum (FCS, Labtech International, UK), 100 U/mL penicillin and 100 mg/mL streptomycin (P/S, Invitrogen Life Technologies, BV, Netherlands) and 1% L-Glutamine. Cells were passaged 48 h prior to transfection by electroporation in a Nucleofector™ 2d Device (Lonza Group Ltd., USA) as described elsewhere . Briefly approximately 2 μg of bTLR5-ptGFP1 construct or empty ptGFP1 vector (control) were used to transfect 106 cells alongside 100 μL Amaxa Nucleofactor solution V, by running program T-030. 500 μl of DMEM, 10% FCS, 1% L-Glutamine and P/S was added to the electrophoresis cuvette and then transferred into tissue culture flasks or plates. After 24 h, all media was replaced with fresh media supplemented with 500 μg/mL of neomycin (G418, Sigma Aldrich, UK). This was replenished every day to remove dead cells, and the concentration of neomycin reduced to 250 μg/mL a week after transfection. Once around 25-50% of the cells were GFP positive, they were cell sorted using a FACSAria™ III which generated a culture with >95% GFP+ cells.
In order to further confirm the presence of bTLR5 in the transfected cells, a PCR was carried out using cDNA obtained from EBL cells transfected with bTLR5-ptGFP1 and empty ptGFP1 vector as template. Forward primer was specific for bTLR5 (bTLR5FW: GTGCCTCGAAGC CTTCAGTTAT) and reverse primer (bTLR5-ptGFP1-RV: CTAGCCGCGGCTCTAGATCAT AATCAG) was designed spanning both bTLR5 and ptGFP1 to ascertain that the amplified fragment was the transfected bTLR5 and not any endogenous TLR5 which could be naturally produced by EBL cells. The reactions for the amplification of the vector/bTLR5 and the endogenous control GAPDH (GAPDH-FW: GATGCTGGTGCTGAGTATGTAGTG and GAPDH-RV: ATCCACAACAGACACGTTGGGAG) was subjected to an initial denaturation of 2 min at 95 °C, followed by 35 cycles of 95 °C for 30 s, 60 °C for 30 s and 72 °C for 45 s using a 25 μL reaction as detailed previously. All PCR products were visualised on a 1% agarose gel containing SYBR® Safe DNA Gel Stain (Life Technologies, BV, Netherlands).
Bovine monocyte-derived macrophages
Bovine monocyte-derived macrophages (MDM) were generated as described previously [28,29], except that the MDM were differentiated for 14 days. In brief, PBMC were initially cultured for 2 h in RPMI-1640 medium without serum at 5 × 106 cells/mL, before the medium was replaced with MDM medium (RPMI-1640 supplemented with 20% FBS, 4 mM L-glutamine and 50 μM β-mercaptoethanol) with 100 U/mL Penicillin-Streptomycin. The MDM medium was replaced on days 4 and 11. On day 14 the adherent cells were rigorously washed with phosphate buffered saline (PBS) and detached with TrypLE Express (Invitrogen). Flow cytometry, using a mouse anti-bovine SIRPα antibody directly conjugated with RPE-Cy5 (AbD Serotec: Cat. No. MCA2041C), confirmed that the MDM purity exceeded 90% (data not shown). Purified MDM were resuspended at 3 × 105 cells/mL in MDM medium without Penicillin-Streptomycin, dispensed into 12 well plates and cultured for 24 h before transfection of siRNA.
Analysis of NfκB activation using a secreted alkaline phosphatase reporter
Cells were treated with trypsin and diluted to be 5 × 105 cell per mL. 180 μL/well of the cells were added to 96 well plate and 20 μL of the required flagella concentration added and incubated with the cells overnight at 37 °C in a 5% CO2 and 80% humidity. Next day 20 μL of the culture media was added to 200 μL of a ready-to-use substrate (Quanti blue) in a 96 well plate format (p7998, Sigma, St. Louis, MI, USA) for 10 min at RT and the readings made at 650 nm using Promega plate reader.
CXCL8/IL8 determination by ELISA
Cells were treated as above and CXCL8/IL8 levels in the cell culture supernatants was assessed following capture with mouse anti-sheep IL-8 and detection with rabbit anti-sheep IL-8 (AbD Serotec, Raleigh, N.C.) followed by goat anti-rabbit IgG conjugated to HRP (DAKO) according to manufacturer’s instructions. Briefly, ELISA plates (Thermoelectron 3455) were coated with mouse anti-sheep CXCL8/IL8 antibody (MCA1660) diluted in carbonate coating buffer (50 μL per well). The plates were sealed and incubated at 4 °C overnight. The plates were washed 6 times in wash buffer (0.05% Triton in PBS) and 100 μL/well blocking buffer (3% bovine serum albumen in wash buffer) was added and incubated at RT for 1 h. Samples and standards were prepared as appropriate in dilution buffer (wash buffer + 1% BSA). Plates were washed 5 times in wash buffer and 50 μL of sample and standard were added in duplicate to the plates. The plates were incubated at RT for 1 h. The plates were then washed 6 times and 50 μL/well of the rabbit anti-sheep IL-8 antibody (AHP425) diluted in dilution buffer was added. The plates were then incubated at RT for 1 h. The plates washed 6 times and 50 μL/well of goat anti-rabbit-HRP (Dako P0448) diluted 1:1000 in RDB was added and incubated at RT for 1 h. The plates were wash 6 times and 100 μL OPD substrate (Sigmafast OPD P9187 Sigma-Aldrich) was added per well and incubated for 5-10 min depending on reaction time of the controls and this varied depending on the room temperature. The reactions were stopped by addition of 50 μL 2.5 M H2SO4 and plates were read at 492 nm using a BMG FLUORstar ELISA reader. The concentration of CXCL8 was determined according to manufacturer’s instructions using recombinant bovine CXCL8 (Kingfisher Biotech, Inc.) to make the standard curve.
We note that sets of experiments were performed with EBL cells at different densities and transfection efficiencies which, in combination with different flagellin preparations may account for variation in CXCL8 levels measured at specific flagellin concentrations between experiments.
Real time PCR analysis of TLR5 and CXCL8 transcripts
Total RNA was extracted from all MDM samples using the RNeasy mini kit (Qiagen), including a DNase digestion step, according to the manufacturer’s instructions. The quality and quantity of the resulting RNA was determined by a Nanodrop spectrophotometer. First strand cDNA was reverse transcribed from 0.2 μg total RNA using an oligo(dT) primer and GoScript reverse transcriptase (Promega) according to the manufacturer’s protocols. The resulting cDNA was diluted 1:20 for RT-qPCR analysis.
Additional primers used in the study
Oligonucleotide sequence (5’ – 3’)
Toll-like receptor 5 (TLR5)
Interleukin 1B (IL1B)
Interleukin/CXCL 8 (IL8/CXCL8)
Maintaining phosphoprotein 1
siRNA knock-down of TLR5
Prior to the experiments reported here, three siRNA duplexes specific for bovine TLR5 (RefSeq Accession No. NM_001040501) were obtained from Sigma-Aldrich and assessed for their ability to knockdown TLR5 mRNA levels. The siRNAs TLR5#2 (target sequence CAATTTCATCCAATTATCA) and TLR5#3(target sequence CGTACAAATACGATGCCUA) were found to consistently knock-down TLR5 mRNA levels between 24 and 96 h. The third siRNA TLR5#1 (target sequence GTCTGAACCCATTCAGAAA) failed to modulate TLR5 mRNA levels. In addition, the AllStars negative control siRNA, which does not share homology with any known mammalian gene (Qiagen), was used as a non-target siRNA control.
The transfection reagent Lipofectamine RNAiMAX (Invitrogen) has previously been shown to be suitable for transfecting siRNA into bovine MDM . The MDM were transfected with siRNA following the manufacturer’s protocol, initially generating a mix of 3 μL Lipofectamine RNAiMAX and 3 μL 20μM siRNA in 200 μL Opti-MEM I reduced serum medium (Invitrogen). After 20 min incubation at RT the siRNA/Lipofectamine RNAiMAX mix was added to MDM in 1 mL MDM medium, giving a final concentration of 50 μM siRNA. Additional controls included in each experiment were MDM treated with Lipofectamine RNAiMAX only (transfection control) and untreated MDM (negative control). After 24 h the medium was replaced with fresh MDM medium to remove the residual siRNA/Lipofectamine RNAiMAX mix.
Immunization of cattle
Immunizations were performed at Moredun Research Institute (MRI) under Home Office licence 60/3179. Ethical approval was obtained from the MRI Animal Experiments Committee. Two groups of conventionally reared male Holstein–Friesian calves (n = 6) were immunized on two separate occasions two weeks apart with either 60 μg of WT-H7 + 5mg Quil A adjuvant (Brenntag Biosector, Frederikssund, Denmark) or 60 μg R90T-H7 + 5 mg Quil A adjuvant via the intra-muscular route. A control group (n = 3) was immunized in an identical manner with adjuvant only. Serum samples were collected at days -1, 7, 21 and 28 relative to the first immunization. The average age of calves at the time of the first immunization was 14 ± 3 weeks. Faecal samples obtained from each calf prior to immunization were confirmed to be negative for E. coli O157:H7 by immunomagnetic separation, performed according to the manufacturer’s instructions (Dynabeads® anti-E. coli O157, Invitrogen).
Measurement of serum immunoglobulin levels
WT-H7 and R90T-H7 specific IgA antibodies were quantified by indirect ELISA as previously described  using LPS-free antigen preparations. Antibody titres were calculated as follows: the log10 optical density (OD) was plotted against the log10 sample dilution and regression analysis of the linear part of the curve allowed the calculation of the endpoint titre with an OD of 0.1 above the average negative control value. Inter-plate variation was normalised to a known positive control sample.
Mixed models were used to analyse each experiment. These models are an extension to ANOVA and take account of variation occurring both between- and within- experiments, and of correlations between measurements repeated over time-points or concentrations. Treatment, concentration (or time) and the treatment by concentration (or time) interaction were fitted as fixed effects, and experiment as a random effect, in each model. Pairwise comparisons between treatment effects at individual concentration (or time) levels were made within each model using t-tests. The variance for these comparisons was determined by the mixed model, taking into account the between- and within- experiment variation. Adjustments were made for multiple testing in the statistical tests. When measurements were not repeated over concentration or time, only treatment was fitted as a fixed effect in the mixed model. Log transformations of the data were used when necessary to ensure that normality requirements for the model were satisfied. The analyses were carried out using the MIXED procedure in the SAS/STAT(r) software. Further information on mixed models may be found in Brown and Prescott .
Signalling from HEK293 cells transfected with human and bovine TLR5 clones
Mutational analysis of H7 flagellin
Analysis of bovine TLR5 activity in bovine epithelial cells
There are possible complications with using the HEK293 cell background to read out for functionality of bTLR5. These include that the adaptor signalling pathways are human not bovine and the possibility of some complementing activity from residual TLR5 activity in the HEK293 cells [17,33], as our non-transfected cells did show a level of activation, especially at high flagellin concentrations (Figure 1A). It was important therefore to test the activity of the bTLR5 clone in a bovine cell context. To our knowledge there are two main immortalized bovine epithelial cell lines that are currently used by research community: Mac-T, a bovine mammary epithelial cell line  and EBLs, an embryonic bovine epithelial cell line (supplied by the Leibniz Institute DSMZ-German Collection of Microorganisms and Cell Cultures). We use EBLs routinely for bacterial infections studies so we investigated whether these cells were able to produce CXCL8 following addition of H7 flagellin. There was no detectable endogenous TLR5 activity in these cells as determined by CXCL8 assays 16 h after addition of up to 10 μg of flagellin (data not shown) and so they were considered an appropriate background in which to study the bTLR5 clone. In order to aid detection and selection of transfected EBLs, the bTLR5 region was sub-cloned into ptGFP1 (Material and Methods) allowing detection of transfected cells through expression of GFP.
The site-directed mutations in the TLR5 binding domain of FliCH7 were tested at 50 ng/mL on EBL cells transfected with bTLR5 (Figure 3C). The R90T, R90A and L500A/I504A constructs all showed significantly reduced levels of CXCL8 secretion compared to stimulation with WT-H7 (p < 0.001). At this flagellin concentration R90T produced lower levels of CXCL8 than the R90A construct (Figure 3C, p < 0.001). Of note was the finding that neither Q89A nor Q89D had any impact on levels of CXCL8 produced compared to WT-H7 at this flagellin concentration while this was not the case when these were tested on the hTLR5 in the HEK293 cells, indicative of different recognition or signalling between the clones and cell types. The R90T flagellin was compared with WT-H7 over a range of concentrations on the bTLR5-EBL cells and shown to induce significantly lower levels of CXCL8 when 50 ng/mL and 500 ng/mL flagellin was added (Figure 3D, p < 0.001). At these concentrations approximately 10-fold more R90T than WT was required to induce an equivalent level of CXCL8 release (Figure 3D).
Analysis of TLR5 responses in bovine primary macrophages derived from PBMCs
In order to assess the requirement of TLR5 for CXCL8 production following flagellin stimulation, three different siRNAs were tested to try and reduce TLR5 transcript levels in the bovine MDMs using established methods . The bovine MDMs were cultured for 48 h following siRNA transfection. TLR5 and CXCL8 mRNA levels are shown at 0 and 24 h following addition of 26.5 ng/mL flagellin (Figures 4B and 4C). It was evident that two of the TLR5 siRNAs, #2 & #3, had significantly reduced levels of TLR5 mRNA at 24 h post flagellin stimulation relative to both non-transfected and scrambled siRNA controls (p < 0.001, Figure 4B). The third siRNA had no effect and is not shown. CXCL8 mRNA levels (Figure 4C) were reduced at 24 h post flagellin addition for the cells transfected with siRNAs #2 & #3 relative to the controls (p < 0.05) and this correlated with a significant reduction in secreted CXCL8 for siRNA #2 at 24 h (p = 0.012) and for siRNA #3 at 24 h (p < 0.001) relative to controls (Figure 4D). Bovine MDMs treated with siRNA #3 produced less CXCL8 in response to crude LPS activation than measured in siRNA #2-treated and control MDMs (data not shown), suggesting another effect of this siRNA on bovine MDM function or viability. This may explain the enhanced effect of siRNA #3 compared to siRNA #2 with respect to CXCL8 mRNA expression and protein secretion. Taken together, these data indicate a positive association of TLR5 expression in bovine MDMs with both CXCL8 mRNA expression and CXCL8 secreted cytokine production in response to addition of H7 flagellin.
To determine if a variant flagellin with reduced TLR5 activation (relative to WT-H7) also had a reduced capacity to stimulate CXCL8 when added to the bovine MDMs, the R90T flagellin was tested. While addition of 50 ng/mL R90T produced significantly lower levels of secreted CXCL8 compared to addition of WT H7 (p = 0.02, Figure 4E), this reduction in secreted CXCL8 levels was only 50% compared to the >10 fold difference demonstrated for the same variant on EBLs expressing bTLR5 (Figure 3C).
Analysis of bovine humoral responses to systemic immunization with WT-H7 flagella and R90T derivative
There is considerable interest in using factors that stimulate pattern recognition receptors (PRRs) as adjuvants. MAMPs are a logical inclusion in vaccine formulations as they stimulate the natural recognition systems allied to host innate and adaptive responses [35,36]. Flagellin monomers are powerful agonists through TLR5 activation as demonstrated in mice and humans [20,37] but their potency to activate TLR5 in cattle is unclear. Our work is focused on responses stimulated by H7 flagellin in cattle for two reasons: (1) generically, as an adjuvant that can stimulate mucosal responses in ruminants; (2) as an antigen to limit EHEC O157:H7 colonisation following vaccination in the reservoir host. Our previous research has demonstrated that systemic immunization with H7 flagella can limit EHEC O157:H7 colonisation possibly by eliciting specific IgA response and high IgG titres [3,8]. The nature of this response was in line with recent findings in mice that have shown the importance of TLR5 in mediating an IgA response to flagellins following systemic injection . However, the responses in cattle were counter to a recent report that indicated minimal activity of cells containing a bovine TLR5 clone . The purpose of the current study was therefore to investigate the functionality of bovine TLR5 using a combination of in vitro and in vivo approaches.
The research presented provides evidence that bovine TLR5 (EMBL ABC68311.1) is functional in terms of flagellin recognition and signalling. The TLR5 clone signalled through an NFkB reporter when transfected into HEK293 cells; the signalling was reduced when specific mutations were introduced into the H7 flagellin TLR5-binding domain. It was apparent that the human clone used in our study did activate the NK-kB reporter to higher levels than the bovine clone in the HEK293 background, at least at when the cells were challenged with lower levels of H7 flagellin. We do not know whether this is due to differences in expression levels of the different TLR5s, and/or signalling activity. Recently reported research on bovine TLR5 by Metcalfe et al.  provided no evidence of bTLR signalling in HEK293T cells and we reasoned that this may be due to: (1) either very low levels of transfection and a different reporter system in their study; (2) differences in signalling in the HEK293 and HEK293T cells based on residual human TLR activity. We have found positively selected codons in the bovine TIR domain which may alter its interactions with MyD88 and other signalling molecules and impact on signalling in cells of different animal origin . To ensure compatibility, we tested the bovine TLR5 clone in a bovine cell line. Prior to transfection, the bovine epithelial cell line, EBL, showed no production of IL8/CXCL8 when flagellin was added. This cell line was then transfected with a bTLR5 sub-clone generated in this study and this resulted in cells that secreted CXCL8 in response to addition of flagella in a dose-dependent manner. This secretion was reduced when the mutated H7 flagellin R90T was added. While this data indicated that the bTLR5 clone is active in response to flagellin in a bovine cell background, further work is required to assess which cells and tissues express TLR5 in cattle. It was interesting that un-transfected EBL cells did not express a TLR5 transcript (data not shown) and were not activated by addition of H7 flagellin; this is in line with reports that udder tissue does not express TLR5  and both bovine primary colonocyte cultures and bovine neutrophils were negative for TLR5 expression [39,40]. A key restriction for future work on cell- and tissue-specific expression is the development of reagents that recognise ruminant TLR5, particularly in its native conformation.
Based on current research, the key cells involved in stimulating host responses to flagellins are most likely specific subsets of dendritic cells and/or macrophages [20,21]. We therefore wanted to analyse TLR5-dependent responses to H7 flagellin by bovine macrophages. Macrophages were derived from blood monocytes  for which RNA silencing methods have been developed . These cells showed detectable expression of TLR5 mRNA which could be knocked down by various TLR5 specific siRNAs. These cells produced CXCL8 mRNA and cytokine in response to flagella and this response was restricted by the anti-TLR5 siRNAs. It was interesting that the level of TLR5 mRNA reduced significantly 4 h following addition of flagellin, indicating that recognition of the agonist leads to a regulatory shift in the sensing cells. However, this immediate repression appeared to be temporary as the TLR5 transcript levels were similar to the initial levels at 24 h, perhaps indicating some type of homeostatic response to continuous flagellin activation. While this study did demonstrate functional TLR5-dependent signalling by bovine macrophages it was evident from the TLR5 knockdowns and studies with the mutated flagellins that other TLR5-independent responses to the flagellins were occurring which did not appear to be the case for the transfected EBL cells. It has been shown that flagellin recognition can also be mediated through cytosolic NAIP and NLRC4-dependent inflammasomes [41,42]. Thus bovine macrophages, unlike bovine EBLs, presumably internalise flagellin into the cytosol, leading to activation of inflammasomes, but further research is required to confirm if this is the case and the consequences of this activation.
To test whether the reduced capacity to stimulate bTLR5 in vitro might alter the humoral IgA response to flagellin, cattle were immunized with either WT-H7 or R90T-H7 flagellin preparations. IgA responses in cattle serum to both flagellins were determined by end-point titration ELISAs. Immunization with the R90T led to levels of serum IgA that were consistently lower than those detected for the WT-H7 irrespective of the coated flagellin antigen used in the ELISA (WT or R90T). However, these differences were not significant (P > 0.05) as a consequence of high titre variation between animals and the relatively small numbers of calves in each group (n = 6). The finding that the variant R90T-H7 was also able to stimulate IgA responses was perhaps not surprising given that this variant was still able to activate bTLR5 signalling, although at a reduced level compared to WT-H7. Differences in vitro were dependent on the amount of flagellin used and how these levels translate to the sensitivity in vivo is unknown. Furthermore the difference in terms of CXCL8 secretion from bovine MDMs stimulated with WT-H7 vs R90T-H7, while significantly reduced for the variant, was less than two-fold at the concentration examined (Figure 4E). As discussed above, it is possible that other TLR5-independent signalling pathways may contribute to the IgA response in cattle following systemic immunization with flagellin. Another consideration for the cattle immunizations experiments is that QuilA was used as an adjuvant and immune stimulating complexes (ISCOMS) containing Quil A can help induce IgA responses when delivered mucosally. However, we are aware from our previous work examining systemic delivery of antigens other than flagellin that Quil A does not usually induce IgA responses to these [8,9]. So while we appreciate there may well be synergy between the adjuvants, QuilA and flagellin, flagellin is required for overt IgA responses.
Proof of TLR5-dependent IgA production in cattle would ideally require cattle that do not express functional TLR5. Recent work has shown that TLR5 alleles are present in cattle with stop codons in the ectodomain which are likely to impair function . However their frequencies would indicate that where present, they would probably be heterozygous. Nonetheless a different stop codon mutation in human TLR5 is a dominant negative mutation and its presence as a heterozygote in humans leads to significantly lower natural levels of flagellin-specific IgG and IgA . Thus it may be possible to investigate whether cattle carrying the STOP codon mutants respond less well to systemic immunisation with H7 flagellin. It may also be possible to identify bovine sires carrying these STOP codons and select homozygotes which would be TLR5 negative, allowing more definitive experiments on the role of bovine TLR5 in vivo.
The TIR domain is important for signal transduction for TLR5, although less is known about the TLR5 signaling motifs and pathways for other TLRs. It is intriguing that the bTLR5 is functional given that it possesses a Y798P change compared to other mammalian TLR5 sequences and that Y798L has been shown to negate TLR5 signalling activity in mice . However, the serine at position 805 may also be critical for signalling , and this is present in the WT bovine TLR5. Evidence suggests that ruminant TLR5 has undergone adaptive evolution which is still ongoing as SNPs were co-localised with predicted adaptive codons . This would suggest that the interactions between flagellins and bovine TLR5 are drivers of evolutionary changes which may have functional consequences in terms of both infectious disease susceptibility and/or inflammatory disorders as described for humans [43,45]. On-going work is investigating the critical residues required for bTLR5 responses and the pathways induced by flagellin recognition. Potentially polymorphisms might account for variation seen in the responses in the flagellin immunisation experiments carried out in the present animal study.
Flores-Langarica et al.  have shown in mice that CD103+ TLR5+ dendritic cell numbers drop in the lamina propria following systemic immunization with flagellins, and that this reduction is associated with an increase in these cells within the local mesenteric lymph nodes. They conclude that this subset of cells traffics to the local node following TLR5-dependent flagellin stimulation to present flagellin peptides to T cells and promote class switching of flagellin-specific B cells to IgA. It has been also been shown that humoral immunity in response to flagellin can depend on other TLR5 independent pathways which involve NAIPs and NLRC4 inflammasome activation  and/or a novel MyD88 independent pathway . Their relevance for cattle is unknown at present. A logical progression of the work in this area is to obtain similar mucosal responses to systemically delivered heterologous antigens expressed either within or conjugated to flagellins. Future work will test immune responses in cattle induced by heterologous flagellin-antigen constructs, as well as defining the specificity of bovine TLR5 stimulation by different flagellin sequences to determine the most appropriate flagellin constructs for use as an adjuvant in this species.
We thank Dr. Jun Zou from the Scottish Fish Immunology Centre, University of Aberdeen for supplying the modified ptGFP1. We thank Dr. Eliza Wolfson for helping with Figure 2. AA, AM, DGES, TM and DLG were supported by grant BB/I011625/1 from the BBSRC; EG and YCM acknowledge BBSRC Industrial Partnership Awards with Bio-Rad AbD Serotec, BB/I020519/1 and BB/I019863/1. DLG, EG, SM, KJ acknowledge support of an Institute Strategic Programme Grant to the Roslin Institute from the BBSRC. TM and DGES receive funding from the Scottish Government.
- Döring G, Meisner C, Stern M, Flagella Vaccine Trial Study Group (2007) Double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients. Proc Natl Acad Sci U S A 104:11020–11025View ArticlePubMed CentralPubMedGoogle Scholar
- Roy K, Hamilton D, Ostmann MM, Fleckenstein JM (2009) Vaccination with EtpA glycoprotein or flagellin protects against colonization with enterotoxigenic Escherichia coli in a murine model. Vaccine 27:4601–4608View ArticlePubMedGoogle Scholar
- McNeilly TN, Naylor SW, Mahajan A, Mitchell MC, McAteer S, Deane D, Smith DG, Low JC, Gally DL, Huntley JF (2008) Escherichia coli O157:H7 colonization in cattle following systemic and mucosal immunization with purified H7 flagellin. Infect Immun 76:2594–2602View ArticlePubMed CentralPubMedGoogle Scholar
- Ricci ML, Torosantucci A, Scaturro M, Chiani P, Baldassarri L, Pastoris MC (2005) Induction of protective immunity by Legionella pneumophila flagellum in an A/J mouse model. Vaccine 23:4811–4820View ArticlePubMedGoogle Scholar
- Mori J, Vranac T, Smrekar B, Cernilec M, Serbec VČ, Horvat S, Ihan A, Benčina M, Jerala R (2012) Chimeric flagellin as the self-adjuvanting antigen for the activation of immune response against Helicobacter pylori. Vaccine 30:5856–5863View ArticlePubMedGoogle Scholar
- Stocker BA, Newton SM (1994) Immune responses to epitopes inserted in Salmonella flagellin. Int Rev Immunol 11:167–178View ArticlePubMedGoogle Scholar
- Westerlund-Wikström B (2000) Peptide display on bacterial flagella: principles and applications. Int J Med Microbiol 290:223–230View ArticlePubMedGoogle Scholar
- McNeilly TN, Mitchell MC, Nisbet AJ, McAteer S, Erridge C, Inglis NF, Smith DG, Low JC, Gally DL, Huntley JF (2010) IgA and IgG antibody responses following systemic immunization of cattle with native H7 flagellin differ in epitope recognition and capacity to neutralise TLR5 signalling. Vaccine 28:1412–1421View ArticlePubMedGoogle Scholar
- McNeilly TN, Mitchell MC, Rosser T, McAteer S, Low JC, Smith DG, Huntley JF, Mahajan A, Gally DL (2010) Immunization of cattle with a combination of purified intimin-531, EspA and Tir significantly reduces shedding of Escherichia coli O157:H7 following oral challenge. Vaccine 28:1422–1428View ArticlePubMedGoogle Scholar
- Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135–145View ArticlePubMedGoogle Scholar
- Song DH, Lee J-O (2012) Sensing of microbial molecular patterns by Toll-like receptors. Immunol Rev 250:216–229View ArticlePubMedGoogle Scholar
- Farhat K, Riekenberg S, Heine H, Debarry J, Lang R, Mages J, Buwitt-Beckmann U, Röschmann K, Jung G, Wiesmüller KH, Ulmer AJ (2008) Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling. J Leukoc Biol 83:692–701View ArticlePubMedGoogle Scholar
- Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SLR, Cookson BT, Aderem A (2003) Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 4:1247–1253View ArticlePubMedGoogle Scholar
- Andersen-Nissen E, Smith KD, Bonneau R, Strong RK, Aderem A (2007) A conserved surface on toll-like receptor 5 recognizes bacterial flagellin. J Exp Med 204:393–403View ArticlePubMed CentralPubMedGoogle Scholar
- Ivicak-Kocjan K, Panter G, Bencina M, Jerala R (2013) Determination of the physiological 2:2 TLR5:flagellin activation stoichiometry revealed by the activity of a fusion receptor. Biochem Biophys Res Commun 435:40–45View ArticlePubMedGoogle Scholar
- Yamamoto M, Takeda K, Akira S (2004) TIR domain-containing adaptors define the specificity of TLR signaling. Mol Immunol 40:861–868View ArticlePubMedGoogle Scholar
- Yoon SI, Kurnasov O, Natarajan V, Hong M, Gudkov AV, Osterman AL, Wilson IA (2012) Structural basis of TLR5-flagellin recognition and signaling. Science 335:859–864View ArticlePubMed CentralPubMedGoogle Scholar
- Andersen-Nissen E, Smith KD, Strobe KL, Barrett SL, Cookson BT, Logan SM, Aderem A (2005) Evasion of Toll-like receptor 5 by flagellated bacteria. Proc Natl Acad Sci U S A 102:9247–9252View ArticlePubMed CentralPubMedGoogle Scholar
- Lee SK, Stack A, Katzowitsch E, Aizawa SI, Suerbaum S, Josenhans C (2003) Helicobacter pylori flagellins have very low intrinsic activity to stimulate human gastric epithelial cells via TLR5. Microbes Infect 5:1345–1356View ArticlePubMedGoogle Scholar
- Flores-Langarica A, Marshall JL, Hitchcock J, Cook C, Jobanputra J, Bobat S, Ross EA, Coughlan RE, Henderson IR, Uematsu S, Akira S, Cunningham AF (2012) Systemic flagellin immunization stimulates mucosal CD103+ dendritic cells and drives Foxp3+ regulatory T cell and IgA responses in the mesenteric lymph node. J Immunol 189:5745–5754View ArticlePubMedGoogle Scholar
- Atif SM, Uematsu S, Akira S, McSorley SJ (2014) CD103-CD11b + dendritic cells regulate the sensitivity of CD4 T-cell responses to bacterial flagellin. Mucosal Immunol 7:68–77View ArticlePubMed CentralPubMedGoogle Scholar
- Smith SA, Jann OC, Haig D, Russell GC, Werling D, Glass EJ, Emes RD (2012) Adaptive evolution of Toll-like receptor 5 in domesticated mammals. BMC Evol Biol 12:122View ArticlePubMed CentralPubMedGoogle Scholar
- Ivison SM, Khan MA, Graham NR, Bernales CQ, Kaleem A, Tirling CO, Cherkasov A, Steiner TS (2007) A phosphorylation site in the Toll-like receptor 5 TIR domain is required for inflammatory signalling in response to flagellin. Biochem Biophys Res Commun 352:936–941View ArticlePubMedGoogle Scholar
- Metcalfe HJ, La Ragione RM, Smith DG, Werling D (2014) Functional characterisation of bovine TLR5 indicates species-specific recognition of flagellin. Vet Immunol Immunopathol 157:197–205View ArticlePubMed CentralPubMedGoogle Scholar
- Ibrahim GF, Fleet GH, Lyons MJ, Walker RA (1985) Method for the isolation of highly purified Salmonella flagellins. J Clin Microbiol 22:1040–1044PubMed CentralPubMedGoogle Scholar
- Corripio-Miyar Y, Secombes CJ, Zou J (2012) Long-term stimulation of trout head kidney cells with the cytokines MCSF, IL-2 and IL-6: Gene expression dynamics. Fish Shellfish Immunol 32:35–44View ArticlePubMedGoogle Scholar
- Vijay-Kumar M, Carvalho FA, Aitken JD, Fifadara NH, Gewirtz AT (2010) TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin. Eur J Immunol 40:3528–3534View ArticlePubMed CentralPubMedGoogle Scholar
- Jensen K, Anderson JA, Glass EJ (2014) Comparison of small interfering RNA (siRNA) delivery into bovine monocyte-derived macrophages by transfection and electroporation. Vet Immunol Immunopathol 158:224–232View ArticlePubMed CentralPubMedGoogle Scholar
- Jensen K, Talbot R, Paxton E, Waddington D, Glass EJ (2006) Development and validation of a bovine macrophage specific cDNA microarray. BMC Genomics 7:224View ArticlePubMed CentralPubMedGoogle Scholar
- Rozen S, Skaletsky H (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132:365–386PubMedGoogle Scholar
- Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res 29:e45View ArticlePubMed CentralPubMedGoogle Scholar
- Brown HK, Prescott RP (2006) Applied Mixed Models in Medicine, 2nd edition. John Wiley, ChichesterView ArticleGoogle Scholar
- Smith MF, Mitchell A, Li G, Ding S, Fitzmaurice AM, Ryan K, Crowe S, Goldberg JB (2003) Toll-like receptor (TLR) 2 and TLR5, but not TLR4, are required for Helicobacter pylori-induced NF-κB activation and chemokine expression by epithelial cells. J Biol Chem 278:32552–32560View ArticlePubMedGoogle Scholar
- Huynh HT, Robitaille G, Turner JD (1991) Establishment of bovine mammary epithelial cells (MAC-T): an in vitro model for bovine lactation. Exp Cell Res 197:191–199View ArticlePubMedGoogle Scholar
- Van Duin D, Medzhitov R, Shaw AC (2006) Triggering TLR signaling in vaccination. Trends Immunol 27:49–55View ArticlePubMedGoogle Scholar
- Reed SG, Bertholet S, Coler RN, Friede M (2009) New horizons in adjuvants for vaccine development. Trends Immunol 30:23–32View ArticlePubMedGoogle Scholar
- Szabó C (2003) Role of flagellin in the pathogenesis of shock and acute respiratory distress syndrome: therapeutic opportunities. Crit Care Med 31:S39–S45View ArticlePubMedGoogle Scholar
- Porcherie A, Cunha P, Trotereau A, Roussel P, Gilbert FB, Rainard P, Germon P (2012) Repertoire of Escherichia coli agonists sensed by innate immunity receptors of the bovine udder and mammary epithelial cells. Vet Res 43:14View ArticlePubMed CentralPubMedGoogle Scholar
- Bridger P, Mohr M, Stamm I, Fröhlich J, Föllmann W, Birkner S, Metcalfe H, Werling D, Baljer G, Menge C (2010) Primary bovine colonic cells: a model to study strain-specific responses to Escherichia coli. Vet Immunol Immunopathol 137:54–63View ArticlePubMedGoogle Scholar
- Conejeros I, Patterson R, Burgos RA, Hermosilla C, Werling D (2011) Induction of reactive oxygen species in bovine neutrophils is CD11b, but not dectin-1-dependent. Vet Immunol Immunopathol 139:308–312View ArticlePubMedGoogle Scholar
- Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI, Aderem A (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1beta via Ipaf. Nat Immunol 7:569–575View ArticlePubMedGoogle Scholar
- Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozören N, Jagirdar R, Inohara N, Vandenabeele P, Bertin J, Coyle A, Grant EP, Núñez G (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages. Nat Immunol 7:576–582View ArticlePubMedGoogle Scholar
- Gewirtz AT, Vijay-Kumar M, Brant SR, Duerr RH, Nicolae DL, Cho JH (2006) Dominant-negative TLR5 polymorphism reduces adaptive immune response to flagellin and negatively associates with Crohn's disease. Am J Physiol Gastrointest Liver Physiol 290:G1157–G1163View ArticlePubMedGoogle Scholar
- Ivison SM, Graham NR, Bernales CQ, Kifayet A, Ng N, Shobab LA, Steiner TS (2007) Protein kinase D interaction with TLR5 is required for inflammatory signaling in response to bacterial flagellin. J Immunol 178:5735–5743View ArticlePubMedGoogle Scholar
- Chantratita N, Tandhavanant S, Myers ND, Chierakul W, Robertson JD, Mahavanakul W, Singhasivanon P, Emond MJ, Peacock SJ, West TE (2014) Screen of whole blood responses to flagellin identifies TLR5 variation associated with outcome in melioidosis. Genes Immun 15:63–71View ArticlePubMed CentralPubMedGoogle Scholar
- López-Yglesias AH, Zhao X, Quarles EK, Lai MA, VandenBos T, Strong RK, Smith KD (2014) Flagellin induces antibody responses through a TLR5- and inflammasome-independent pathway. J Immunol 192:1587–1596View ArticlePubMed CentralPubMedGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.